Please don't hesitate to contact us if you have any questions or other inquiries.

The Society for Immunotherapy of Cancer's (SITC) 36 Annual Meeting

The 36th Annual Meeting of the Society for Immunotherapy in Cancer – SITC 2021 – will take place 10 – 14 November 2021 in Washington, DC, USA.

Our Oncology team will join virtually and explore if our biomarker for neutrophil activity can be used for immunotherapy in different solid tumor types.

Christina Jensen and Nicholas Willumsen will present two posters at the upcoming SITC Annual Meeting.

In one of them, we show that high levels of a serum calprotectin assay (CPa9-HNE), as a measure of neutrophil activity, are associated with poor response to anti-PD-1 therapy in metastatic melanoma patients.

Furthermore, we observed elevated CPa9-HNE levels in patients with different solid tumor types. These findings may indicate that CPa9-HNE may be used as a biomarker for anti-PD-1 therapy across different solid tumor types.

We hope to see you there!

 

Please don't hesitate to contact us if you have any questions or other inquiries.

Are you interested in learning more about Nordic Bioscience?
Enter your information in the form and a representative will contact you shortly.

By submitting this form you agree to our terms and conditions.

We use cookies on our site to enable essential services and functionalities, and collect data in regards to visitor information to provide the best possible experience. By using our website, you agree to our Privacy Policy and our cookies usage. Cookie Policy Privacy Statement